Meet-URO Score Validation in Real-world Patients with Metastatic Renal Cell Carcinoma Receiving First-line Pembrolizumab Plus axitinib: A Subanalysis of the Prospective ProPAXI Study
在接受一线帕博利珠单抗联合阿昔替尼治疗的转移性肾细胞癌患者中验证Meet-URO评分:前瞻性ProPAXI研究的亚组分析
期刊:Journal of Kidney Cancer and VHL
影响因子:1.9
doi:10.15586/jkc.v12i4.403
Airò, Giulia; Guida, Annalisa; Gili, Alessio; Signori, Alessio; Rebuzzi, Sara Elena; Maruzzo, Marco; Lai, Eleonora; Pierantoni, Francesco; Bimbatti, Davide; Basso, Umberto; Damassi, Alessandra; Calabrò, Fabio; Cerbone, Linda; Caserta, Claudia; Sirgiovanni, Grazia; Serafin, Debora; Caffo, Orazio; Scagliarini, Sarah; Bracarda, Sergio; Buti, Sebastiano